MedEdge Holdings completed the acquisition of Abyrx and Kairuku for $450m.

MedEdge Holdings, a holding company that acquires, manages, and builds commercial-stage surgical product companies, completed the acquisition of Abyrx, a company that develops, manufactures, and commercializes a portfolio of biosurgical solutions, and Kairuku, a proprietary desktop and mobile software platform, for $450m. The new capital will enable MedEdge Holdings to acquire and in-license additional commercial-stage surgical products. Initial efforts will focus on products with early commercial traction that offer clear improvements over legacy technologies used in the same surgical settings where Abyrx's products are already established. Priority will be given to proprietary, competitively priced products with attractive margins and strong alignment with Abyrx's and Kairuku's existing distribution channels. MedEdge expects to acquire 10–15 companies over the next several years, each anticipated to be immediately accretive and to have meaningful growth potential.